The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at Delhi AIIMS on Friday and the first dose of the injection was administered...
from NDTV News - Special https://ift.tt/3eZbY7z
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment